2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$10.70-$0.37 (-3.34%)
Price as of Oct 22, 2026 7:56 PM EDT- $314.6MMarket Cap
- -4.07%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$10.70-$0.37 (-3.34%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.07 | ||
Change | +$0.09 (+0.82%) | ||
Open | $11.11 | ||
High | $11.34 | ||
Low | $11.05 | ||
Previous Close | $10.98 | ||
Volume | 341,807 | ||
30-Day Average Volume | 743,535 | ||
1-Week Change | -0.45% | ||
1-Month Change | -24.64% | ||
1-Year Change | -4.07% | ||
3-Year Change | -45.14% | ||
5-Year Change | -75.16% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $224.3M | ||
Market Cap | $314.6M | ||
Enterprise Value | $123.2M | ||
Period: QTR TTM FY | |||
Revenue | $880,000.00 | ||
Net Income | -$23.8M | ||
Free Cash Flow | -$19.9M | ||
EBIT | -$23.8M | ||
EBITDA | -$23.1M | ||
Net Working Capital | $163.6M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 140 | ||
P/B | 2 | ||
P/E | -13 | ||
PEG | -1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue